• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC in the Press, December 2, 2016

Article

A review of our peer-reviewed research in the healthcare and mainstream press.

The Patient Engagement HIT website featured an article on a recent American Journal of Managed Care (AJMC) study, “Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation.” It discussed the study’s argument that healthcare industry stakeholders and CMS should consider modifications to the patient engagement requirements as the optional reporting period for Stage 3 Meaningful Use approaches.

Care of Adults with Chronic Childhood Conditions, a guidebook published by Springer, cited an AJMC study in the chapter “Adherence and Self-Management.” The cited study discussed how text messaging could be used for chronic disease management.

MedPage Today published a compilation of cardiology news items that included an article from AJMC’s coverage of the 2016 meeting of the American College of Rheumatology. The article discussed a new study presented at the meeting suggesting that “a test used to predict future disease activity in patients with rheumatoid arthritis (RA) might someday tell physicians which patients are at risk for cardiovascular events, such as heart attacks or coronary infection.”

An article in BMC Public Health, “Healthy and Productive Workers: Using Intervention Mapping to Design a Workplace Health Promotion and Wellness Program to Improve Presenteeism,” referenced an AJMC study. That study, “A Systematic Review of Measurement Properties of Instruments Assessing Presenteeism,” examined the relative value of instruments that measure presenteeism (decreased productivity while at work).

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.